Introduction
============

Peptic ulcer is a debilitating disease which affects 4 million people of all ages globally each year.[@b1-dddt-8-2099],[@b2-dddt-8-2099] This prevalent gastrointestinal disorder is defined as integrity disturbance of the duodenum or gastric mucosa, which is characterized by mucosal damage due to gastric acid and pepsin secretion.[@b3-dddt-8-2099],[@b4-dddt-8-2099] The gastrointestinal inflammation caused by a peptic ulcer can deteriorate into a perforated peptic ulcer and become a life-threatening disease, with the mortality rate of 10%--40%.[@b5-dddt-8-2099]--[@b7-dddt-8-2099] The increased incidence of contributing factors to peptic ulcer among people, including alcohol consumption, nutritional deficiencies, smoking, and stress has made this disease a major health problem of global concern.[@b8-dddt-8-2099]--[@b10-dddt-8-2099] In addition, the available therapeutic drugs for peptic ulcers have failed to meet pharmacological expectations, to a certain degree, due to arrhythmia, gynecomastia, hypersensitivity, impotence, and hematopoietic changes of drugs, including anticholinergics, H~2~-receptor antagonists, and proton pump inhibitors.[@b11-dddt-8-2099],[@b12-dddt-8-2099] Therefore, there is a surge of interest in developing new pharmacological agents with gastroprotective effect against peptic ulcers.

Investigation into different diseases at the cellular level and exploring the molecular pathway have provided a new approach for the development of pharmacological products.[@b13-dddt-8-2099] In recent studies, it is well established that heat shock proteins (Hsps) have a critical role in the gastric defense mechanism at the intracellular level.[@b14-dddt-8-2099]--[@b16-dddt-8-2099] Hsp70, as a major molecular chaperone, is responsible for cellular recovery against various stimuli, through modulation of the denatured and unfolded proteins.[@b17-dddt-8-2099],[@b18-dddt-8-2099] The protective role of this protein against gastric mucosal damage induced by ulcerogenic conditions and toxic agents has made it a key factor in gastrointestinal studies.[@b19-dddt-8-2099]--[@b21-dddt-8-2099] Therefore, studies on antiulcer agents with the potential to increase the expression of Hsp70 can lead to the development of new gastroprotective drugs with marked improvements in efficiency.

*Annona muricata* L., a member of the Annonaceae family, is a widely distributed plant in Central and South America and tropical countries.[@b22-dddt-8-2099],[@b23-dddt-8-2099] Also known as soursop and graviola, this small tropical tree plant has long been cultivated by native peoples, due to its extensive applications in folk medicine and heart-shaped, edible fruits.[@b24-dddt-8-2099],[@b25-dddt-8-2099] The lanceolate dark green leaves of *A. muricata* are traditionally used as an antispasmodic nervine for heart conditions and as a sedative. In addition, the leaves are applied to treat asthma, cough, fever, headache, hypertension, and toothache.[@b24-dddt-8-2099],[@b26-dddt-8-2099],[@b27-dddt-8-2099] The leaves of *A. muricata* have been found to possess significant antioxidant effects, assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity, ferric reducing antioxidant power, and hydroxyl-scavenging activity techniques in animal models.[@b23-dddt-8-2099],[@b26-dddt-8-2099],[@b28-dddt-8-2099] In addition, the leaves demonstrated a notable protective effect against acute and chronic inflammations in rats, through suppression of proinflammatory cytokines.[@b29-dddt-8-2099] Previous studies have shown that the main chemical constituents in *A. muricata* are annonaceous acetogenins, alkaloids, and essential oils.[@b24-dddt-8-2099] Due to the significant antioxidant and anti-inflammatory features of *A. muricata* leaves, this plant may be a promising candidate for antiulcer agents. Hence, the present study was carried out to investigate the acute toxicity and gastroprotective activity of *A. muricata* leaves against ethanol-induced gastric injury in rats.

Materials and methods
=====================

Plant collection and preparation of the ethyl acetate extract
-------------------------------------------------------------

The leaves of *A. muricata* were collected from Ipoh, Malaysia, in June 2013. The plant was authenticated by Dr Yong Kien Thai, Institute of Biological Sciences, University of Malaya. A voucher specimen has been deposited at the herbarium of the University of Malaya (Number KLU47978). The leaves were dried at 35°C and subsequently powdered (1,981 g), followed by maceration at room temperature with ethyl acetate for 4 days. After filtering the extract, the solvent was removed using a rotary evaporator (Buchi, Germany) at 40°C. The percentage yield after extraction, three times with ethyl acetate was 4.1% (81.3 g).

Drugs and chemicals
-------------------

In this study, omeprazole (Sigma-Aldrich, St Louis, MO, USA) was used as the reference antiulcer medicine. All substances administered to animals, including ethyl acetate extract of *A. muricata* leaves (EEAM) and omeprazole, were dissolved in the vehicle (5% Tween^®^ 20).

Chemical analysis of EEAM
-------------------------

Chemical profiling of EEAM was carried out using an Agilent, a LECO Restek Rxi^®^-5MS capillary column (30 minutes, 0.25 mm internal diameter, 0.25 μm film thickness), and a LECO Pegasus^®^ HT high throughput time-of-flight mass spectrometer, as previously described in detail.[@b30-dddt-8-2099] The carrier gas was helium, at a flow rate of 1 mL per minute (min). Column temperature was initially 40°C for 5 min, then gradually elevated to 160°C at 4°C/min, and finally increased to 280°C at 5°C/min and held for 10 min. For gas chromatography-- mass spectrometry detection, an electron ionization system was used, with ionization energy of 70 eV. The fraction was diluted 1:100 (by volume) with ethyl acetate, and 1.0 μL of the diluted sample was injected automatically in splitless mode. Injector temperature was set at 250°C. Compounds were identified from their mass spectra, by comparison of the retention times of peak with interpretation of mass spectroscopy fragmentation patterns from the National Institute of Standards and Technology (NIST147) mass specteral database.

Animals
-------

Adult and healthy Sprague Dawley^®^ strain rats (180--250 g) of both sexes were obtained from Animal House, Faculty of Medicine, University of Malaya (Kuala Lumpur, Malaysia). Animals were housed at controlled room temperature (\~24°C) with free access to standard rat pellets and tap water ad libitum, under an artificial lighting system (daily ratio 1:1). The experiments were carried out after approval of the protocol by the committee for animal experimentation, Faculty of Medicine, University of Malaya (Ethic Number 2014-03-05/PHAR/R/SZM).

Toxicity evaluation of EEAM
---------------------------

Eighteen female rats (6--8 weeks old) were divided into three groups (n=6), namely, vehicle, low dose, and high dose, and orally administered with Tween 20 (5%), 1 g/kg EEAM, and 2 g/kg EEAM, respectively. Prior to dosing, rodents were fasted overnight (water was accessible), and fasting was continued for 3 hours after dosing. The rats were then monitored for mortality, if any, or any other sign of toxicological symptoms twice per day during a period of 2 weeks. On day 15, the rats were euthanized using an overdose of xylazine and ketamine, and tested for biochemical parameters and histological examinations of liver and kidney.

Ethanol-induced gastric injury
------------------------------

The experiment was performed as previously described in detail.[@b31-dddt-8-2099] After 24 hours of fasting (water was accessible except for the last 2 hours), the 30 male rats (n=6 per group) in five groups were pretreated according to [Table 1](#t1-dddt-8-2099){ref-type="table"}. To induce gastric injury, 1 hour after treatment, all the rodents were orally administered with absolute ethanol (5 mL/kg), except for the normal control group, which was administered with 5% Tween 20. The rats were euthanized 1 hour later with an overdose of xylazine and ketamine, and their stomachs were removed and prepared for further analysis.

Macroscopic evaluation of lesions
---------------------------------

After rinsing the stomachs of the rats with water to remove blood clots and gastric contents, they were opened along the greater curvature and fixed to examine the gastric lesion index, as previously described.[@b32-dddt-8-2099] Microscopic scores were calculated, based on the following parameters: edema or hemorrhage, loss of mucosal folding, mucosal discoloration (score: 1 each); ulcers less than 1 mm/cm^2^ (score: number of ulcers ×2); ulcers more than 1 mm/cm^2^ (score: number of ulcers ×3); perforated ulcers (score: number of ulcers ×4).

Evaluation of the loss in gastric wall mucus (GWM) and gastric juice acidity
----------------------------------------------------------------------------

To determine gastric juice acidity, the stomachs were dissected and the contents were drained into falcon tubes and centrifuged at 3,000 rpm for 15 min. Then, gastric acidity was measured using a digital pH meter. Perturbation in GWM was determined for each group.[@b33-dddt-8-2099] In brief, the glandular segments of each stomach were removed prior to immersing the stomach tissue in 1% alcian blue solution (in sucrose solution, buffered with sodium acetate at pH 5). Then, the excess dye was removed by rinsing with sucrose solution. Magnesium chloride solution was used to extract the dye complexed with GWM. After mixing the extract with diethyl ether, the level of GWM in each group was determined through measurement of the absorbance at 580 nm. The quantity of GWM was expressed as μg of alcian blue per gram of tissue.

Enzymatic activities of stomach tissue homogenate
-------------------------------------------------

Preparation of the gastric tissue homogenate (150 mg tissue/mL phosphate buffered saline) for each rat was performed using a teflon homogenizer (Polytron, Heidolph, Germany). Then, the supernatant of tissue homogenate was isolated after centrifugation at 4,000 rpm for 10 min and used for further assessment of enzymatic activities. The levels of catalase (CAT), glutathione (GSH), nitric oxide (NO), and superoxide dismutase (SOD) were determined using commercial kits (Cayman Chemical, Ann Arbor, MI, USA), according to the vendor's instructions. In addition, determination of the levels of malondialdehyde (MDA) and prostaglandin E2 (PGE-2) was also carried out using commercial kits (Cayman Chemical), based on the protocols provided by the manufacturer.

Histopathology
--------------

Stomachs were fixed in 10% formalin. For microscopic analysis, after processing the tissues in a paraffin tissue-processing machine (Leica Microsystems Incorporated, Nussloch, Germany), 5 μm sections of tissue were stained with hematoxylin and eosin (H&E) dye and Periodic acid--Schiff (PAS) dye (Sigma-Aldrich), to examine tissue architecture, and changes in glycogen and generated mucus, respectively. Lastly, a light microscope (Nikon, Tokyo, Japan) was used to observe the gastric sections.

Immunohistochemistry evaluation
-------------------------------

Immunohistochemistry analysis of Bax and Hsp70 was carried out, as previously described in detail.[@b34-dddt-8-2099],[@b35-dddt-8-2099] Briefly, after processing the specimens of gastric tissue as previously mentioned, 5 μm sections were fixed on 3-aminopropyltrimethoxysilane-(APES) treated glass slides and supplemented with Bax and Hsp70 (Abcam, Cambridge, MA, USA), for immunohistochemical staining using a streptavidin peroxidase (Abcam). The slides were then observed under a light microscope with brown color representing positive immunohistochemical staining.

Statistical analysis
--------------------

All values were reported as mean ± standard error of n animals per group. Statistical evaluation of the data was carried out using one-way analysis of variance, followed by Tukey's test. In the cases of ulcer index and gastric juice acidity, data were analysed using the Kruskal--Wallis test, and Dunn's multiple comparison test, as a post hoc test. A value of *P*\<0.05 was considered significant.

Results and discussion
======================

Nutraceuticals, including dietary supplements, functional foods, and herbal products have maintained their importance in the treatment of various ailments and diseases, irrespective of the extensive development of synthetic drugs in the pharmaceutical industry.[@b36-dddt-8-2099] In recent years, considering the prominence of gastric injury and unpredictable side effects of the long-term use of synthetic drugs, interest in the use of herbal products has markedly elevated.[@b37-dddt-8-2099] Previous studies have illustrated that numerous plants from different families, including Annonaceae, possess promising antiulcer properties.[@b37-dddt-8-2099],[@b38-dddt-8-2099] An in vitro and in vivo study on *A. squamosa*, a member of the Annonaceae family, showed that the twigs of this plant possess antiulcer constituents with suppressive effect on H^+^ K^+^-ATPase activity.[@b39-dddt-8-2099] *Uvaria chamae* leaves (Annonaceae), with extensive application in folk medicine, are an antiulcer herb, scientifically proven to have antiulcer activity in rats.[@b40-dddt-8-2099] *Polyalthia longifolia*, belonging to the Annonaceae family, was found to have anti-inflammatory and antiulcer properties in its fresh leaves, associated with antioxidant activity.[@b41-dddt-8-2099],[@b42-dddt-8-2099] In the current study, we investigated the antiulcer effects of EEAM against ethanol-induced gastric injury in rats.

Chemical profiling of EEAM
--------------------------

The chemical profiling of EEAM showed the presence of two major compounds, namely, caryophyllene and α-copaene ([Figure 1](#f1-dddt-8-2099){ref-type="fig"}). Previous studies showed that among 80 essential oil compounds detected in *A. muricata* leaves, caryophyllene was the most abundant constituent (13.6%).[@b43-dddt-8-2099],[@b44-dddt-8-2099] A recent investigation exhibited that the antioxidant effect of β-caryophyllene can effectively protect the rat liver from carbon tetrachloride-induced fibrosis, by suppressing hepatic stellate cell activation.[@b45-dddt-8-2099] Caryophyllene oxide isolated from the bark of *A. squamosa* demonstrated significant anti-inflammatory and analgesic activities.[@b46-dddt-8-2099] In addition, α-copaene was also reported as one of the significant chemical constituents (2.0%--7.3%) detected in volatile oil contents of *A. muricata*.[@b47-dddt-8-2099] Caryophyllene and α-copaene were previously found to have promising antioxidant activity when they were isolated from *A. salzmannii*.[@b48-dddt-8-2099] Considering the anti-inflammatory and antioxidant activities reported for caryophyllene and α-copaene, as the major compounds detected in EEAM, this extract may be a potential antiulcer candidate against ethanol-induced gastric injury in rats.

EEAM safety
-----------

Examination of acute toxicity is the first step in the study of the biological activities of plants.[@b49-dddt-8-2099] In this study, no mortality in rats was observed with two concentrations of the EEAM extract (1 g/kg and 2 g/kg). After 2 weeks of treatment with EEAM, the rats did not demonstrate important changes in body weight, behavior (ie, ataxia, hypoactivity, and hyperactivity), microscopic morphology, and functional tests of kidney and liver ([Table 2](#t2-dddt-8-2099){ref-type="table"} and [Figure 2](#f2-dddt-8-2099){ref-type="fig"}). From these results, it is concluded that EEAM is quite safe, even at the highest dose of 4 g/kg, with no detectable sign of acute toxicity; the oral lethal dose (LD~50~) of EEAM in rats was higher than 2 g/kg body weight. Our result was comparable with a previous investigation on the ethanol extract from *A. muricata* leaves, which showed an LD~50~ of 1.67 g/kg in mice, presenting high safety of *A. muricata* leaves.[@b50-dddt-8-2099] However, a previous study on the acute toxicity of *A. muricata* leaf aqueous extract reported the relatively low LD~50~ value of 155 mg/kg in mice, which showed moderate safety of aqueous extract in mice.[@b27-dddt-8-2099]

Macroscopic analysis of gross appearances of stomach and gastric ulcer index
----------------------------------------------------------------------------

The rodents that were administrated with absolute ethanol experienced severe macroscopic damage, compared to the normal control group ([Figure 3A](#f3-dddt-8-2099){ref-type="fig"}), which was evidenced by development of hemorrhagic ulceration ([Figure 3B](#f3-dddt-8-2099){ref-type="fig"}). The consequent hemorrhagic detriment was conspicuously attenuated by pretreatment with EEAM at 200 mg/kg and 400 mg/kg doses, with a few fields of hyperemia ([Figure 3C and 3D](#f3-dddt-8-2099){ref-type="fig"}). In addition, rats with prior administration of omeprazole (20 mg/kg) were able to suppress damage to the stomach, showing similar features to the normal control group ([Figure 3E](#f3-dddt-8-2099){ref-type="fig"}). Macroscopic analysis of the gross appearances of the stomach demonstrated that EEAM administration, especially at 400 mg/kg dose, had a protective effect against ethanol-induced gastric injury, which was comparable to the protective effect of omeprazole, as a standard antiulcer drug.

In the ethanol-induced gastric injury model, pretreatment with EEAM at 200 mg/kg and 400 mg/kg doses caused significant inhibition on the ulcer lesion index, compared to the ulcer control group ([Figure 3](#f3-dddt-8-2099){ref-type="fig"}). In addition, there was a significant reduction in all the gastric ulcer parameters after preadministration with omeprazole, as a standard antiulcer drug ([Figure 3](#f3-dddt-8-2099){ref-type="fig"}). This proton pump inhibitor drug has been extensively used to treat various ailments regarding gastric acid secretion.[@b51-dddt-8-2099] Besides the antisecretory effect of omeprazole in acid-dependent ulcer models, it is well known to have a mucosal protective effect in non-antisecretory doses.[@b52-dddt-8-2099] The noteworthy healing rates of omeprazole among patients suffering from peptic ulcer are mainly due to its gastric mucosa-protective effect, associated with the ability to suppress gastric juice acidity via proton pump inhibitory activity.[@b53-dddt-8-2099] Therefore, any herbal medicine with the same protective effects may possibly show promising antiulcer potential.[@b54-dddt-8-2099] Hence, in the next step of this study, we investigated the effect of EEAM on GWM and gastric juice acidity.

EEAM protected the GWM and attenuated gastric juice acidity
-----------------------------------------------------------

Among the various factors involved in the intensification of lesion ulcers, exogenous gastric acid is known to be a crucial aggressive factor in the stomach.[@b55-dddt-8-2099] The excessive production of gastric acid in patients suffering from peptic ulcers can severely intensify the gastric injury, which generally parallels reduction in the level of GWM.[@b56-dddt-8-2099] Perturbation in the balance between aggressive factors and defensive factors, including cellular mucus, cell proliferation, cell shedding, and mucus secretion, results in gastric hyperacidity.[@b57-dddt-8-2099] In patients with peptic ulcers, proton pump inhibitors attenuate acid secretion in the stomach and recover the production of GWM.[@b4-dddt-8-2099] It is well established that ethanol is a potent necrotizing agent that severely damages the protective factors of the mucosa.[@b58-dddt-8-2099] In our study, after administration of ethanol to rats, levels of GWM and pH were significantly reduced, compared to the normal control group ([Figure 4](#f4-dddt-8-2099){ref-type="fig"}). However, pretreatment of rats with two doses of EEAM caused significant attenuation in gastric acidity, compared to the ulcer control group. In addition, EEAM significantly retrieved the loss in GWM. Nonetheless, rats pretreated with omeprazole had comparatively higher protection of GWM and lower gastric acidity, compared to EEAM at both doses ([Figure 4](#f4-dddt-8-2099){ref-type="fig"}).

EEAM induced changes in enzymatic activities of stomach tissue homogenate
-------------------------------------------------------------------------

Administration of absolute ethanol to rodents induced significant reduction in antioxidant activities and NO level of stomach homogenate, compared to the normal control group. Meanwhile, pretreatment with EEAM at two doses, and omeprazole, significantly surged the levels of antioxidant activities and NO ([Table 3](#t3-dddt-8-2099){ref-type="table"}). It is well established that reactive oxygen species (ROS), including hydrogen peroxide, hydroxyl radicals, and superoxide anions, as an aggressive factor, have a critical role in oxidative damage to the gastric mucosa.[@b59-dddt-8-2099] Cellular antioxidants maintain ROS at their physiological levels to attenuate tissue damages. The higher level of GSH was found to minimize oxidative damages.[@b60-dddt-8-2099] By converting into glutathione disulfide; this tripeptide with thiol groups reduces cellular ROS.[@b61-dddt-8-2099] In addition, SOD has a scavenging effect against ROS, by converting the superoxide to hydrogen peroxide, which is subsequently converted to water by CAT.[@b62-dddt-8-2099]

One of the important factors for the slow flow of gastric blood, which leads to the development of hemorrhagic lesions and subsequent solubilization of gastric mucus contents, was found to be a reduction in the level of NO. This leads to an elevation in the flow of K^+^, Na^+^, and pepsin secretion associated with a loss in the level of H^+^ ions.[@b63-dddt-8-2099] The protective barrier produced by NO, through the suppression of neutrophil infiltration, inhibits gastric damage from ethanol.[@b64-dddt-8-2099] Through an inhibitory effect on neutrophil infiltration, NO also attenuates the secretion of inflammatory mediators.[@b65-dddt-8-2099] Therefore, antiulcer agents with the ability to promote NO production can provide a more protective effect against gastric lesions.

The level of MDA, as a final product of lipid peroxidation, is an easy biomarker to determine oxidative stress.[@b66-dddt-8-2099] Lipid peroxidation is mediated by neutrophils, via generation of superoxide anions.[@b65-dddt-8-2099] As a necrotizing agent, ethanol caused an increase in the level of MDA,[@b67-dddt-8-2099] which was observed in our study after administration of absolute ethanol to rats in the normal control group ([Table 3](#t3-dddt-8-2099){ref-type="table"}). As is to be expected, due to the elevation in the activity of antioxidants, pretreatment with EEAM significantly suppressed MDA production in gastric tissue, which was close to the omeprazole effect ([Table 3](#t3-dddt-8-2099){ref-type="table"}).

Prostaglandins, due to the regulatory effect on the function of the gut, have promising potential in the treatment of different gastric ailments.[@b68-dddt-8-2099] PGE-2 with E prostanoid receptors has a critical role in the motility and secretion of the stomach. Previous studies have shown that the cytoprotective effect of PGE-2 provides noteworthy resistance to gastric mucosal cells against strong irritants, including ethanol.[@b69-dddt-8-2099],[@b70-dddt-8-2099] In our study, the ulcer control group showed significant reduction in the level of PGE-2, while rats in groups C--E demonstrated compensatory increases. However, omeprazole administration to rats caused the highest level of PGE-2 in gastric tissue homogenates ([Table 3](#t3-dddt-8-2099){ref-type="table"}).

Histopathological effect of EEAM on gastric lesions
---------------------------------------------------

As was observed in the macroscopic appearance, histological analysis of the gastric tissues also demonstrated various microscopic characterizations, as illustrated in [Figures 5](#f5-dddt-8-2099){ref-type="fig"} and [6](#f6-dddt-8-2099){ref-type="fig"}. H&E staining of the gastric tissues illustrated the severe superficial injury induced by ethanol ([Figure 5](#f5-dddt-8-2099){ref-type="fig"}). Apparent features of gastric ulcers, including edema and leukocyte infiltration, were observed in the lesion control group. Histological analysis indicated that oral administration of EEAM (200 mg/kg and 400 mg/kg doses), and omeprazole, markedly protected the gastric tissues from hemorrhagic lesions associated with attenuation of leukocyte infiltration and submucosal edema. In spite of a conspicuous protective effect of EEAM, the sign of hemorrhagic lesions was clearly evident in EEAM 200 mg/kg pretreated rats. Nonetheless, administration of EEAM at 400 mg/kg dose, and omeprazole, demonstrated approximately the same characterizations as the normal control group ([Figure 5](#f5-dddt-8-2099){ref-type="fig"}).

Glycogen production in the gastric epithelium was examined using PAS staining. The glycogen content in gastric mucosa, presented as magenta color in PAS staining, showed an almost similar level in all groups of rats, except the lesion control, which suggested a collapse in glycogen production in this group ([Figure 6](#f6-dddt-8-2099){ref-type="fig"}). The PAS staining intensity was elevated in the pretreated groups of rats, with EEAM and omeprazole, compared to the lesion control group, showing the beneficial effect of EEAM on glycogen generation. Induction of glycogen formation by EEAM at 400 mg/kg dose approximates the effect of omeprazole. The findings of histopathological staining confirmed the role of EEAM, particularly at 400 mg/kg dose, in the enhancement of mucus level.

EEAM induced up-regulation of Hsp70 and down-regulation of Bax
--------------------------------------------------------------

Hsp70, a low-molecular weight chaperone and a member of the four families of heat shock proteins, has a critical role in the posttranslational characterizations of polypeptides.[@b71-dddt-8-2099] Previous studies have shown the cytoprotective role of Hsp70 against different stress conditions.[@b72-dddt-8-2099]--[@b74-dddt-8-2099] In the current study, immunohistochemical analysis showed that mucosal expression of Hsp70 was upregulated in EEAM-and omeprazole-pretreated groups ([Figure 7](#f7-dddt-8-2099){ref-type="fig"}). However, accumulation of Hsp70 in the gastric tissue of rats pretreated with omeprazole was comparable to rats pretreated with EEAM. The normal control group also elicited a higher level of Hsp70 expression, compared to the lesion control group ([Figure 7](#f7-dddt-8-2099){ref-type="fig"}).

A Bcl-2 family of proteins, with 25 members, consists of two groups of proapoptotic and antiapoptotic proteins.[@b75-dddt-8-2099] Bax, a proapoptotic protein, promotes the induction of apoptosis in stressed cells via mitochondrial-initiated events.[@b76-dddt-8-2099],[@b77-dddt-8-2099] Therefore, an inhibitory effect on Bax protein expression attenuates cellular damage to the gastric tissue.[@b78-dddt-8-2099] As illustrated in [Figure 8](#f8-dddt-8-2099){ref-type="fig"}, the expression of Bax protein in the lesion control group was markedly higher, compared to the normal control group, representing the undergoing process of apoptosis among gastric cells. In pretreated rats with EEAM at 200 mg/kg and 400 mg/kg doses, and omeprazole, accumulation of Bax protein in gastric tissue was noticeably reduced ([Figure 8](#f8-dddt-8-2099){ref-type="fig"}). Administration of EEAM (400 mg/kg), and omeprazole, reduced Bax protein expression to approximately the level of the normal control group. However, rats treated with EEAM at 200 mg/kg dose still elicited the accumulation of Bax protein in gastric tissue ([Figure 8](#f8-dddt-8-2099){ref-type="fig"}).

Conclusion
==========

The results obtained in this study showed the safety of EEAM in rats, even at the highest dose of 2 g/kg. However, further chronic toxicity testing should be conducted to confirm its safe usage. In vivo study in rats demonstrated the promising antiulcer effect of EEAM against gastric mucosal injury induced by ethanol. EEAM mediated its antiulcer potential probably through its ROS-scavenging activity and protective effect against GWM damage. In addition, Hsp70 upregulation and Bax downregulation were found to be involved in the suppression of gastric injuries. However, an investigation on the major active compound in EEAM is still required, to fully illustrate the antiulcer potential of *Annona muricata* leaves.
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![A chromatogram analysis of EEAM, characterized with the GC-MS-TOF.\
**Notes:** GC-MS-TOF analysis demonstrated the presence of two major compounds, namely (1) caryophyllene and (2) α-copaene.\
**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; GC-MS-TOF, gas chromatography--time-of-flight mass spectrometry; AIC, analytical ion chromatogram.](dddt-8-2099Fig1){#f1-dddt-8-2099}

![Histopathology analysis (H&E staining, 20×) of kidney and liver from control, EEAM at 1 g/kg, and EEAM at 2 g/kg demonstrated no significant differences in the structures of kidney and liver between vehicle control and EEAM-treated groups.\
**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; H&E, hematoxylin and eosin.](dddt-8-2099Fig2){#f2-dddt-8-2099}

![Gross appearances of stomach from five groups of rats, namely: (**A**) normal control, (**B**) lesion control, (**C**) low dose of EEAM, (**D**) high dose of EEAM, and (**E**) omeprazole control. Quantitative analysis of ulcer index showed significant reduction in the ulcer index after pretreatment with EEAM (200 mg/kg and 400 mg/kg), and omeprazole.\
**Notes:** Data are reported as means ± SEM of six animals per group. Statistical comparison was performed using the Kruskal--Wallis test, followed by the Dunn test. A value of \**P*\<0.05 was considered significant.\
**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; SEM, standard error of the mean.](dddt-8-2099Fig3){#f3-dddt-8-2099}

![Measurement of (**A**) GWM (μg of alcian blue per gram of tissue) and (**B**) pH in five groups of rats, namely: (A) normal control, (B) lesion control, (C) low dose of EEAM, (D) high dose of EEAM, and (E) omeprazole control.\
**Notes:** Data for GWM are reported as means ± SEM of six animals per group. Statistical comparison for the median pH values was performed using the Kruskal--Wallis test, followed by the Dunn test. A value of \**P*\<0.05 was considered significant.\
**Abbreviations:** GWM, gastric wall mucus; EEAM, ethyl acetate extract of *Annona muricata* leaves; SEM, standard error of the mean.](dddt-8-2099Fig4){#f4-dddt-8-2099}

![Histopathological staining of gastric tissues after treatment with EEAM at (**C**) 200 mg/kg and (**D**) 400 mg/kg doses, and (**E**) omeprazole, using H&E staining (20×). (**A**) and (**B**) are presenting the normal control and lesion control groups, respectively. In the lesion control group, there are clear signs of severe damage to the surface epithelium (white arrow) and leukocyte infiltration (yellow arrow).\
**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; H&E, hematoxylin and eosin.](dddt-8-2099Fig5){#f5-dddt-8-2099}

![Histopathological staining of gastric tissues after treatment with EEAM at (**C**) 200 mg/kg and (**D**) 400 mg/kg doses, and (**E**) omeprazole, using PAS staining (20×). (**A**) and (**B**) are presenting the normal control and lesion control groups, respectively. PAS staining illustrated the glycogen accumulation (red arrow) in rats pretreated with EEAM and omeprazole.\
**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; PAS, Periodic acid--Schiff.](dddt-8-2099Fig6){#f6-dddt-8-2099}

![Immunohistochemical analysis of Hsp70 expression from five groups of rats, namely: (**A**) normal control, (**B**) lesion control, (**C**) low dose of EEAM, (**D**) high dose of EEAM, and (**E**) omeprazole control. Immunohistochemistry staining showed upregulation of Hsp70 in groups **C**--**E**. (**A**) and (**B**) are presenting the normal control and lesion control groups, respectively. The yellow arrow shows Hsp70 accumulation in gastric tissue (20×).\
**Abbreviation:** EEAM, ethyl acetate extract of *Annona muricata* leaves.](dddt-8-2099Fig7){#f7-dddt-8-2099}

![Immunohistochemical analysis of Bax protein expression from five groups of rats, namely: (**A**) normal control, (**B**) lesion control, (**C**) low dose of EEAM, (**D**) high dose of EEAM, and (**E**) omeprazole control. Immunohistochemistry staining showed downregulation of Bax in groups **C**--**E**. (**A**) and (**B**) are presenting the normal control and lesion control groups, respectively. The red arrow shows Bax protein accumulation in gastric tissue (20×).\
**Abbreviation:** EEAM, ethyl acetate extract of *Annona muricata* leaves.](dddt-8-2099Fig8){#f8-dddt-8-2099}

###### 

The experimental design and specifications

  Group   Description          Pretreatment               Treatment
  ------- -------------------- -------------------------- ------------------
  A       Normal control       5% Tween^®^ 20 (5 mL/kg)   5% Tween 20
  B       Ulcer control        5% Tween 20 (5 mL/kg)      Absolute ethanol
  C       Low dose             EEAM (200 mg/kg)           Absolute ethanol
  D       High dose            EEAM (400 mg/kg)           Absolute ethanol
  E       Omeprazole control   Omeprazole (20 mg/kg)      Absolute ethanol

**Abbreviation:** EEAM, ethyl acetate extract of *Annona muricata* leaves.

###### 

Effects of EEAM on renal and liver function tests of rats after 14 days of acute toxicity study did not show any significant differences between vehicle control and EEAM treated groups

  ------------------------------------------------------------------------------------------------------------------------------------------
  Renal function test                                                                                                            
  ------------------------- -------------------- -------------- --------------- ------------ ----------- ----------- ----------- -----------
  Vehicle                   141.5±0.6            3.91±0.05      105.7±0.9       23.1±0.2     17.3±0.4    6.3±0.2     30.6±1.5    

  1 g/kg                    140.6±0.3            4.14±0.07      104.3±1.1       24.4±0.3     16.6±0.3    5.8±0.1     30.7±1.2    

  2 g/kg                    140.7±0.4            4.22±0.03      104.4±1.0       25.1±0.2     16.9±0.6    5.6±0.2     31.8±1.1    

                                                                                                                                 

  **Liver function test**                                                                                                        

                                                                                                                                 

  **Group**                 **Total protein**\   **Albumin**\   **Globulin**\   **TB**\      **AP**\     **ALT**\    **AST**\    **GGT**\
                            **(g/L)**            **(g/L)**      **(g/L)**       **(μM/L)**   **(U/L)**   **(U/L)**   **(U/L)**   **(U/L)**

                                                                                                                                 

  Vehicle                   70.5±0.7             35.4±0.8       27.3±0.8        3.1±0.1      160.4±2.4   27.4±0.9    25.1±2.2    1.1±0.1

  1 g/kg                    71.4±0.3             36.6±0.4       26.5±0.4        3.2±0.2      159.3±1.9   28.2±1.1    27.5±1.5    1.0±0.1

  2 g/kg                    71.7±0.8             37.1±0.2       26.1±0.2        3.2±0.1      158.5±2.5   28.9±1.5    26.3±1.4    1.2±0.1
  ------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Values expressed as mean ± SEM. A value of *P*\<0.05 was considered significant.

**Abbreviations:** EEAM, ethyl acetate extract of *Annona muricata* leaves; TB, total bilirubin; AP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase; SEM, standard error of the mean.

###### 

Effect of EEAM at (C) 200 mg/kg and (D) 400 mg/kg doses, and (E) omeprazole on enzymatic activities of stomach tissue homogenate. (A) and (B) are presenting the normal control and lesion control groups, respectively

  ---------------------------------------------------------------------------------------------------------------------
  Animal group   CAT\            GSH\              NO\              SOD\             MDA\             PGE-2\
                 nM/min/mL       (μM/mg protein)   (μM/g protein)   (U/mg protein)   (μM/g protein)   (ng/mg protein)
  -------------- --------------- ----------------- ---------------- ---------------- ---------------- -----------------
  A              116.11±4.17     16.49±0.44        11±0.9           19.66±0.25       72.23±1.1        4.07±0.09

  B              70.14±3.21      9.19±0.38         5.7±0.09         10.19±0.55       168.23±4.98      2.12±0.03

  C              81.53\*±2.11    12.51\*±0.18      7.7\*±0.7        12.89\*±0.56     123.88\*±6.71    2.8\*±0.1

  D              103.23\*±4.21   13.49\*±0.12      9.1\*±1.1        14.79\*±0.61     95.22\*±0.22     3.4\*±0.7

  E              113.23\*±5.1    15.02\*±0.33      10.1\*±1         17.11\*±0.7      89.23\*±0.41     3.8\*±0.06
  ---------------------------------------------------------------------------------------------------------------------

**Notes:** Data are reported as means ± SEM of six animals per group. A value of \**P*\<0.05 was considered significant.

**Abbreviation:** EEAM, ethyl acetate extract of *Annona muricata* leaves; CAT, catalase; GSH, glutathione; NO, nitric oxide; SOD, superoxide dismutase; MDA, malondialdehyde; PGE-2, prostaglandin E2; SEM, standard error of the mean.
